HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)

A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).
Also Known As:
Familial Hypercholesterolemia; Hypercholesterolemia, Familial; Apolipoprotein B-100, Familial Defective; Apolipoprotein B-100, Familial Ligand-Defective; Familial Combined Hyperlipoproteinemia; Hyper-Low Density Lipoproteinemia; Hyper-Low-Density-Lipoproteinemia; Hyper-beta-Lipoproteinemia; Hypercholesterolemia, Autosomal Dominant; Hypercholesterolemia, Autosomal Dominant, Type B; Hypercholesterolemic Xanthomatosis, Familial; Hyperlipoproteinemia Type 2; Hyperlipoproteinemia Type IIa; Hyperlipoproteinemia Type IIb; Hyperlipoproteinemia, Type II; Hyperlipoproteinemia, Type IIa; LDL Receptor Disorder; Apolipoprotein B 100, Familial Defective; Apolipoprotein B 100, Familial Ligand Defective; Autosomal Dominant Hypercholesterolemia; Autosomal Dominant Hypercholesterolemias; Combined Hyperlipoproteinemia, Familial; Combined Hyperlipoproteinemias, Familial; Density Lipoproteinemia, Hyper-Low; Density Lipoproteinemias, Hyper-Low; Disorder, LDL Receptor; Disorders, LDL Receptor; Dominant Hypercholesterolemia, Autosomal; Dominant Hypercholesterolemias, Autosomal; Essential Hypercholesterolemia; Essential Hypercholesterolemias; Familial Combined Hyperlipoproteinemias; Familial Hypercholesterolemias; Familial Hypercholesterolemic Xanthomatoses; Familial Hypercholesterolemic Xanthomatosis; Hyper Low Density Lipoproteinemia; Hyper beta Lipoproteinemia; Hyper-Low Density Lipoproteinemias; Hyper-Low-Density-Lipoproteinemias; Hyper-beta-Lipoproteinemias; Hyperbetalipoproteinemias; Hypercholesterolemias, Autosomal Dominant; Hypercholesterolemias, Essential; Hypercholesterolemias, Familial; Hypercholesterolemic Xanthomatoses, Familial; Hyperlipoproteinemia Type 2s; Hyperlipoproteinemia Type IIas; Hyperlipoproteinemia Type IIbs; Hyperlipoproteinemia Type IIs; Hyperlipoproteinemia, Familial Combined; Hyperlipoproteinemias, Familial Combined; Hyperlipoproteinemias, Type II; Hyperlipoproteinemias, Type IIa; LDL Receptor Disorders; Lipoproteinemia, Hyper-Low Density; Lipoproteinemias, Hyper-Low Density; Receptor Disorder, LDL; Receptor Disorders, LDL; Type 2, Hyperlipoproteinemia; Type II Hyperlipoproteinemia; Type II Hyperlipoproteinemias; Type IIa Hyperlipoproteinemia; Type IIa Hyperlipoproteinemias; Xanthomatoses, Familial Hypercholesterolemic; Xanthomatosis, Familial Hypercholesterolemic; Hyperbetalipoproteinemia; Hypercholesterolemia, Essential
Networked: 4283 relevant articles (184 outcomes, 484 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Atherosclerosis
2. Cardiovascular Diseases (Cardiovascular Disease)
3. Hypercholesterolemia
4. Coronary Artery Disease (Coronary Atherosclerosis)
5. Dyslipidemias (Dyslipidemia)

Experts

1. Kastelein, John J P: 107 articles (01/2022 - 07/2002)
2. Santos, Raul D: 56 articles (03/2022 - 07/2005)
3. Watts, Gerald F: 47 articles (06/2022 - 03/2002)
4. Mata, Pedro: 45 articles (01/2022 - 04/2002)
5. Civeira, Fernando: 43 articles (11/2022 - 04/2002)
6. Defesche, Joep C: 43 articles (01/2022 - 12/2002)
7. Wiegman, Albert: 42 articles (03/2022 - 03/2003)
8. Hovingh, G Kees: 41 articles (01/2022 - 02/2012)
9. Nohara, Atsushi: 40 articles (01/2022 - 05/2002)
10. Hegele, Robert A: 39 articles (04/2022 - 03/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Hyperlipoproteinemia Type II:
1. oxidized low density lipoproteinIBA
2. LDL CholesterolIBA
3. Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
4. CholesterolIBA
5. LipidsIBA
6. LDL Lipoproteins (beta Lipoproteins)IBA
7. alirocumabIBA
8. LDL Receptors (LDL Receptor)IBA
9. Lovastatin (Mevacor)FDA LinkGeneric
10. Atorvastatin (Lipitor)FDA Link

Therapies and Procedures

1. Therapeutics
2. Blood Component Removal (Apheresis)
3. Plasma Exchange
4. Conservative Treatment
5. Diet Therapy (Therapy, Diet)